Raymond James Financial Inc. acquired a new stake in shares of JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 319,857 shares of the company’s stock, valued at approximately $18,715,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of the business. FMR LLC increased its holdings in JPMorgan International Research Enhanced Equity ETF by 34.6% in the 3rd quarter. FMR LLC now owns 12,172,036 shares of the company’s stock worth $803,720,000 after buying an additional 3,127,580 shares during the period. LPL Financial LLC increased its holdings in JPMorgan International Research Enhanced Equity ETF by 21.5% in the 3rd quarter. LPL Financial LLC now owns 2,776,806 shares of the company’s stock worth $183,353,000 after buying an additional 492,080 shares during the period. Assetmark Inc. increased its holdings in JPMorgan International Research Enhanced Equity ETF by 1.1% in the 4th quarter. Assetmark Inc. now owns 1,586,042 shares of the company’s stock worth $92,799,000 after buying an additional 16,797 shares during the period. Bogart Wealth LLC increased its holdings in JPMorgan International Research Enhanced Equity ETF by 10.6% in the 4th quarter. Bogart Wealth LLC now owns 818,247 shares of the company’s stock worth $47,876,000 after buying an additional 78,668 shares during the period. Finally, New England Professional Planning Group Inc. increased its holdings in JPMorgan International Research Enhanced Equity ETF by 2.0% in the 4th quarter. New England Professional Planning Group Inc. now owns 738,485 shares of the company’s stock worth $43,209,000 after buying an additional 14,250 shares during the period.
JPMorgan International Research Enhanced Equity ETF Trading Up 1.0 %
Shares of NYSEARCA:JIRE opened at $65.60 on Tuesday. JPMorgan International Research Enhanced Equity ETF has a twelve month low of $57.55 and a twelve month high of $67.10. The company’s 50 day moving average is $62.31 and its 200 day moving average is $62.66. The company has a market cap of $6.49 billion, a PE ratio of 17.19 and a beta of 0.92.
JPMorgan International Research Enhanced Equity ETF Profile
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Further Reading
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- Top Biotech Stocks: Exploring Innovation Opportunities
- Can TikTok Stock Picks Really Make You Rich?
- Golden Cross Stocks: Pattern, Examples and Charts
- The “Quality” Rotation: Back to Basics Investing
- When to Sell a Stock for Profit or Loss
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.